BIOMAT Database Logo BIOMAT Database Logo

Simultaneous pancreas/kidney transplantation: comparison of mycophenolate mofetil versus azathioprine. 1998

E A Elkhammas, and S Yilmaz, and M L Henry, and J Yenchar, and G L Bumgardner, and R P Pelletier, and R M Ferguson
Ohio State University, Department of Surgery, Columbus 43210, USA.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001379 Azathioprine An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed) Azathioprine Sodium,Azathioprine Sodium Salt,Azathioprine Sulfate,Azothioprine,Immuran,Imuran,Imurel,Sodium, Azathioprine
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016035 Pancreas Transplantation The transference of a pancreas from one human or animal to another. Grafting, Pancreas,Transplantation, Pancreas,Graftings, Pancreas,Pancreas Grafting,Pancreas Graftings,Pancreas Transplantations,Transplantations, Pancreas
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

E A Elkhammas, and S Yilmaz, and M L Henry, and J Yenchar, and G L Bumgardner, and R P Pelletier, and R M Ferguson
A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
December 1998, Transplantation,
E A Elkhammas, and S Yilmaz, and M L Henry, and J Yenchar, and G L Bumgardner, and R P Pelletier, and R M Ferguson
Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine.
June 1998, Transplantation proceedings,
E A Elkhammas, and S Yilmaz, and M L Henry, and J Yenchar, and G L Bumgardner, and R P Pelletier, and R M Ferguson
Mycophenolate mofetil versus enteric-coated mycophenolate sodium after simultaneous pancreas-kidney transplantation.
December 2009, Transplantation proceedings,
E A Elkhammas, and S Yilmaz, and M L Henry, and J Yenchar, and G L Bumgardner, and R P Pelletier, and R M Ferguson
Comparison of azathioprine and mycophenolate mofetil in pancreas transplantation.
March 1998, Transplantation proceedings,
E A Elkhammas, and S Yilmaz, and M L Henry, and J Yenchar, and G L Bumgardner, and R P Pelletier, and R M Ferguson
Mycophenolate mofetil versus azathioprine in organ transplantation.
December 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
E A Elkhammas, and S Yilmaz, and M L Henry, and J Yenchar, and G L Bumgardner, and R P Pelletier, and R M Ferguson
Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
July 2000, Transplantation,
E A Elkhammas, and S Yilmaz, and M L Henry, and J Yenchar, and G L Bumgardner, and R P Pelletier, and R M Ferguson
Mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation: a single-center experience.
April 2000, Clinical nephrology,
E A Elkhammas, and S Yilmaz, and M L Henry, and J Yenchar, and G L Bumgardner, and R P Pelletier, and R M Ferguson
The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.
November 2000, Transplantation proceedings,
E A Elkhammas, and S Yilmaz, and M L Henry, and J Yenchar, and G L Bumgardner, and R P Pelletier, and R M Ferguson
Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
June 2003, Transplantation,
E A Elkhammas, and S Yilmaz, and M L Henry, and J Yenchar, and G L Bumgardner, and R P Pelletier, and R M Ferguson
Immunosuppression in pancreas transplantation: mycophenolate mofetil versus sirolimus.
May 2004, Transplantation proceedings,
Copied contents to your clipboard!